IP Library Granted Patent US 7,411,052
Granted Patent B2
US 7,411,052 · App. 10/488,423 · Granted Aug 12, 2008

Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,411,052
App. No.
10/488,423
Granted
Aug 12, 2008
Kind
B2
Abstract

The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted stem cell growth factor-like polypeptides. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

Claims (11)

1. An isolated polypeptide comprising an amino acid sequence which is at least 99% identical to the amino acid sequence selected from the group consisting of SEQ ID NO:18, or 27.

2. An isolated polypeptide comprising an amino acid sequence which is at least 95% identical to the amino acid sequence selected from the group consisting of SEQ ID NO: 18 or 27.

3. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 18 or 27.

4. A composition comprising the polypeptide of claims 1 , 2 or 3 and a pharmaceutically acceptable carrier.

5. The polypeptide of claim 3 produced by the process comprising:

a) culturing a host cell comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 17 or 26, or the mature protein portion thereof, under conditions sufficient to express the polypeptide in said cell; and

b) isolating the polypeptide from the cell culture or cells in step (a).

6. A method of producing the polypeptide of claim 3 , comprising:

a) culturing a host cell comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 17 or 26, or the mature protein portion thereof, under conditions sufficient to express the polypeptide in said cell; and

b) isolating the polypeptide from the cell culture or cells in step (a).

7. An isolated polypeptide encoded by a polynucleotide selected from the group consisting of SEQ ID NO: 17 or 26, or the mature protein coding portion thereof.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 022235 FRAME 0181. ASSIGNOR CONFIRMS THE ASSIGNMENT. Recorded Mar 20, 2009
From: NUVELO, INC.
To: ARCA BIOPHARMA, INC.
Reel/Frame 022427/0425 →
RE-RECORD TO CORRECT THE NAME OF THE ASSIGNEE, PREVIOUSLY RECORDED ON REEL 022235 FRAME 0181. Recorded Mar 20, 2009
From: NUVELO, INC.
To: ARCA BIOPHARMA, INC.
Reel/Frame 022427/0431 →
MERGER Recorded Feb 9, 2009
From: NUVELO, INC.
To: ARCA BIOPHARAM, INC.
Reel/Frame 022235/0181 →
CORRECTIVE ASSIGNMENT TO CORRECT THE TITLE. THE FILING DATE IS NOT INDICATED. PREVIOUSLY RECORDED ON REEL 014827 FRAME 0629. ASSIGNOR(S) HEREBY CONFIRMS THE TITLE: \"TP\" SHOULD BE \"TO\". FILE DATE IS 03/03/2004. PTO ERROR - NO FEE DUE!!. Recorded Jul 9, 2004
From: TANG, Y. TOM
To: NUVELO, INC.
Reel/Frame 014831/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2004
From: TANG, Y. TOM
To: NUVELO, INC.
Reel/Frame 014827/0629 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2004
From: TANG, Y. TOM
To: NUVELO, INC.
Reel/Frame 017423/0727 →